MedKoo Cat#: 527716 | Name: MBC-11

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MBC-11 is bone resorption factor inhibitor potentially for the treatment of bone lesions, caused by multiple myeloma, metastatic breast and prostate cancer. MBC-11 reduced the incidence of bone metastases to 40%. MBC-11 also significantly decreased bone tumor burden compared to PBS- or zoledronate-treated mice.

Chemical Structure

MBC-11
MBC-11
CAS#332863-86-2

Theoretical Analysis

MedKoo Cat#: 527716

Name: MBC-11

CAS#: 332863-86-2

Chemical Formula: C11H20N3O14P3

Exact Mass: 511.0158

Molecular Weight: 511.21

Elemental Analysis: C, 25.84; H, 3.94; N, 8.22; O, 43.81; P, 18.18

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
MBC-11; MBC 11; MBC11
IUPAC/Chemical Name
(1-((((((2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)-1-hydroxyethyl)phosphonic acid
InChi Key
HUIKCRXUQCSUJS-ZLRZYOKSSA-N
InChi Code
InChI=1S/C11H20N3O14P3/c1-11(18,29(19,20)21)30(22,23)28-31(24,25)26-4-5-7(15)8(16)9(27-5)14-3-2-6(12)13-10(14)17/h2-3,5,7-9,15-16,18H,4H2,1H3,(H,22,23)(H,24,25)(H2,12,13,17)(H2,19,20,21)/t5-,7-,8+,9-,11?/m1/s1
SMILES Code
O=C1N=C(N)C=CN1[C@H]2[C@H]([C@@H]([C@@H](COP(OP(C(C)(O)P(O)(O)=O)(O)=O)(O)=O)O2)O)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 511.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Reinholz MM, Zinnen SP, Dueck AC, Dingli D, Reinholz GG, Jonart LA, Kitzmann KA, Bruzek AK, Negron V, Abdalla AK, Arendt BK, Croatt AJ, Sanchez-Perez L, Sebesta DP, Lönnberg H, Yoneda T, Nath KA, Jelinek DF, Russell SJ, Ingle JN, Spelsberg TC, Dixon HB, Karpeisky A, Lingle WL. A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites. Bone. 2010 Jul;47(1):12-22. doi: 10.1016/j.bone.2010.03.006. PubMed PMID: 20233612; PubMed Central PMCID: PMC2892200.